000 | 00952cam a22002534a 4500 | ||
---|---|---|---|
001 | vtls003211230 | ||
003 | MY-SjTCS | ||
005 | 20200226114441.0 | ||
008 | 110218s2010 njua b 001 0 eng | ||
020 | _a9780470229651 (hbk.) | ||
020 | _a0470229659 (hbk.) | ||
039 | 9 |
_a201102181351 _bVLOAD _c201011291517 _dshuhada _c201011291505 _dshuhada _y201010181540 _zmalathy |
|
082 | 0 | 0 |
_a615.798 _bMAT 2010 |
100 | 1 |
_aMatthews, David J. _q(David John), _d1965- _947482 |
|
245 | 1 | 0 |
_aTargeting protein kinases for cancer therapy / _cDavid J. Matthews, Mary E. Gerritsen. |
260 |
_aHoboken, N.J. : _bJohn Wiley, _cc2010. |
||
300 |
_axiii, 702 p. : _bill. (chiefly col.) ; _c25 cm. |
||
504 | _aIncludes bibliographical references and index. | ||
650 | 0 |
_aProtein kinases _xInhibitors _xTherapeutic use. |
|
650 | 0 | _aAntineoplastic agents. | |
650 | 0 |
_aProtein kinases. _947483 |
|
700 | 1 |
_aGerritsen, Mary E. _947484 |
|
920 | _aPHA : 152895 | ||
999 |
_c132623 _d132623 |